New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DUBLIN, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan's Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio.ERS, co-founded by Dr. Emmanuelle C...
Authors: LATEST ASIANET NEWS RELEASES